Pharmacokinetic Study of ORM-12741 in Healthy Volunteers
- First Posted Date
- 2009-01-08
- Last Posted Date
- 2009-10-08
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 12
- Registration Number
- NCT00818740
- Locations
- 🇫🇮
CRST, Turku, Finland
Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741
- First Posted Date
- 2009-01-06
- Last Posted Date
- 2009-03-16
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 6
- Registration Number
- NCT00817544
- Locations
- 🇳🇱
PRA International, AE Zuitlaren, Netherlands
Safety and Tolerability Study With Multiple Ascending Doses of ORM-12741
- First Posted Date
- 2008-11-18
- Last Posted Date
- 2009-09-24
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 51
- Registration Number
- NCT00792493
- Locations
- 🇫🇷
Forenap Pharma, Rouffach, France
Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU
- First Posted Date
- 2008-09-05
- Last Posted Date
- 2009-04-21
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 13
- Registration Number
- NCT00747721
- Locations
- 🇫🇮
Turku University Hospital, Turku, Finland
Suitability of 11C-ORM-13070 as a PET Tracer
- First Posted Date
- 2008-08-15
- Last Posted Date
- 2009-11-25
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 18
- Registration Number
- NCT00735774
- Locations
- 🇫🇮
Turku PET centre, Turku, Finland
Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables
- Conditions
- Transient Ischemic AttackStroke
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2009-11-25
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 32
- Registration Number
- NCT00698763
- Locations
- 🇫🇮
Helsinki University Hospital (HUCH), Helsinki, Finland
🇫🇮Turku University Hospital (TYKS), Turku, Finland
🇩🇪Heidelberg University Clinic, Heidelberg, Germany
Safety and Tolerability Study With Single Ascending Doses of ORM-12741
- First Posted Date
- 2008-06-09
- Last Posted Date
- 2010-02-11
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 120
- Registration Number
- NCT00693316
- Locations
- 🇫🇷
Forenap Pharma, Rouffach, France
Pharmacokinetic Study With Repeated Doses of Stalevo
- Conditions
- Pharmacokinetics
- Interventions
- Drug: levodopa, carbidopa
- First Posted Date
- 2008-06-09
- Last Posted Date
- 2008-06-09
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 19
- Registration Number
- NCT00693862
- Locations
- 🇫🇮
Pharmacokinetics laboratory/Department of Pharmacology and Toxicology, Kuopio, Finland
🇫🇮NEURO, Helsinki, Finland
🇫🇮Turku University Hospital, Turku, Finland
Comparison of PEG Solutions With and Without Electrolytes in the Treatment of Constipation
- Conditions
- Constipation
- Interventions
- Drug: Polyethylene glycol 4000 with electrolytes
- First Posted Date
- 2008-01-29
- Last Posted Date
- 2008-10-07
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 67
- Registration Number
- NCT00603681
- Locations
- 🇫🇮
Tampereen sotainvalidien Veljeskoti, Tampere, Finland
🇫🇮Vire Koti Kaukaharju assisted-living facility, Tampere, Finland
🇫🇮Taatala assested-living facility, Tampere, Finland
PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding
- Conditions
- Parkinson´s Disease
- Interventions
- First Posted Date
- 2007-11-21
- Last Posted Date
- 2008-06-16
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 16
- Registration Number
- NCT00562198
- Locations
- 🇫🇮
Oulu University Hospital, Department of Neurology, Oulu, Finland
🇫🇮Helsinki University Hospital, Department of Neurology, Helsinki, Finland
🇫🇮CRST, Turku, Finland